Liquidia Inc. (LQDA) - Koefisien utang jangka dawa marang modal

The market trend for Liquidia Corporation (LQDA) shown on this price chart reflects the dynamics of a company implementing ESG principles through plant modernization and the reduction of plastics in inhalers, with the indicator standing at 0.65. The business relies on partnerships with laboratories to develop pulmonary disease medications, yet faces patent disputes and regulatory barriers that hinder product commercialization.

The long-term debt-to-equity ratio determines the proportion of liabilities with a maturity exceeding one year relative to shareholders' equity, allowing for an assessment of financial leverage and long-term borrowing risks. By analyzing the history of the long-term debt-to-equity ratio, investors confirm the stability of Liquidia Corporation (LQDA), where a steady cash flow from pulmonary hypertension drugs ensures a confident increase in the business's financial health.